ROSI, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 1.196
AS - Asia 1.106
EU - Europa 758
SA - Sud America 109
Continente sconosciuto - Info sul continente non disponibili 44
AF - Africa 29
OC - Oceania 12
Totale 3.254
Nazione #
US - Stati Uniti d'America 1.135
CN - Cina 365
IT - Italia 266
SG - Singapore 242
RU - Federazione Russa 182
PL - Polonia 108
BD - Bangladesh 103
VN - Vietnam 98
KR - Corea 97
HK - Hong Kong 86
BR - Brasile 77
CA - Canada 36
DE - Germania 35
FR - Francia 34
IE - Irlanda 30
JP - Giappone 27
IN - India 24
SE - Svezia 21
GB - Regno Unito 16
CH - Svizzera 14
AU - Australia 12
JO - Giordania 12
BE - Belgio 10
MX - Messico 10
FI - Finlandia 9
AR - Argentina 8
NL - Olanda 8
AE - Emirati Arabi Uniti 7
TR - Turchia 7
UA - Ucraina 7
VE - Venezuela 6
DK - Danimarca 5
IQ - Iraq 5
JM - Giamaica 5
KE - Kenya 5
PY - Paraguay 5
EC - Ecuador 4
ID - Indonesia 4
NG - Nigeria 4
PH - Filippine 4
PK - Pakistan 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BJ - Benin 3
CO - Colombia 3
DZ - Algeria 3
KG - Kirghizistan 3
NP - Nepal 3
SA - Arabia Saudita 3
AT - Austria 2
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ES - Italia 2
HR - Croazia 2
IL - Israele 2
PE - Perù 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AI - Anguilla 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.210
Città #
Ashburn 226
Singapore 169
Santa Clara 151
Hefei 127
Warsaw 107
Seoul 96
Hong Kong 81
San Jose 68
Fairfield 58
Milan 56
Council Bluffs 44
Rome 43
Ann Arbor 41
The Dalles 38
Seattle 37
Ho Chi Minh City 32
Beijing 30
Dublin 29
Los Angeles 28
New York 26
Tokyo 25
Woodbridge 25
Chandler 23
Buffalo 22
Munich 20
Houston 19
Wilmington 17
Florence 16
Lauterbourg 15
Cambridge 14
Dallas 14
Hanoi 13
Kent 12
Bern 11
Turin 10
Brussels 9
Shenzhen 9
São Paulo 9
Bengaluru 8
Melbourne 8
Naples 8
Toronto 8
Genoa 7
Shanghai 7
Boardman 6
Chennai 6
Frankfurt am Main 6
Lawrence 6
London 6
Princeton 6
Altamura 5
Haiphong 5
Massapequa 5
Moscow 5
Newark 5
Palermo 5
Turku 5
Abuja 4
Asunción 4
Bologna 4
Boston 4
Brasília 4
Chicago 4
Clifton 4
Mumbai 4
Orem 4
Paris 4
San Diego 4
San Francisco 4
Tianjin 4
Valby 4
Venice 4
Amsterdam 3
Bari 3
Bắc Giang 3
Cotonou 3
Figino 3
Helsinki 3
Kingston 3
Lugano 3
Manchester 3
Maracaibo 3
Nairobi 3
Oxnard 3
Redondo Beach 3
Rio de Janeiro 3
Taranto 3
Tashkent 3
Thái Bình 3
Amman 2
Austin 2
Bakersfield 2
Barr 2
Bishkek 2
Brooklyn 2
Bình Phước 2
Cagliari 2
Catania 2
Charlotte 2
Colmar 2
Totale 2.020
Nome #
Immunoglobulin replacement therapy for yellow nail syndrome 310
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 206
The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome 195
Does the body weight influence the outcome in children treated with robotic pyeloplasty? 195
Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of caspofungin in a population of critically ill septic patients 168
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis Suppurativa 163
Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections 160
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits 117
Comment on ‘Morphology: the mother of all biomarkers’ 114
Monozygotic twins affected by SAPHO syndrome 114
Th2 Cytokines Affect the Innate Immune Barrier without Impairing the Physical Barrier in a 3D Model of Normal Human Skin 112
Discoid lupus erythematosus affecting the scalp 112
Anti-Interleukin-17s for successful management of pustular psoriasis 109
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study 105
The Relevant Oral Burden of Patients with Hidradenitis Suppurativa 104
Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy 103
Assessment of therapeutic response to photodynamic therapy with the Zn-Phthalocyanine RLP068/Cl versus topical Clindamycin in patients affected by Hidradenitis Suppurativa: a comparative clinical pilot study 100
Therapy of PsO in Special Subsets of Patients 89
Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With Apremilast 79
Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience 78
REDUCED SLEEP QUALITY AND DECREASED EXECUTIVE PERFORMANCE IN PATIENTS WITH PSORIASIS 75
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 60
SUBJECTIVE SLEEP QUALITY IN PSORIATIC PATIENTS AND ITS ASSOCIATION WITH SYMPTOMS SEVERITY 50
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 50
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study 37
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 30
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 27
Azathioprine-induced acute generalized exanthematous pustulosis in a woman with autoimmune hepatitis 26
Long-term, real-world effectiveness of adalimumab in the treatment of hidradenitis suppurativa 24
Risankizumab in very elderly patients in real-world practice 24
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study 24
Rethinking antibiotic use in hidradenitis suppurativa: a call for stewardship 22
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 19
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa 18
Erythema multiforme as a rare skin manifestation during pembrolizumab treatment: a case report and literature review 16
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review 11
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa 8
Totale 3.254
Categoria #
all - tutte 8.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202247 0 0 2 5 1 2 4 4 3 5 7 14
2022/2023130 14 19 10 6 8 18 15 4 18 0 5 13
2023/202438 3 2 5 1 2 10 1 5 1 3 2 3
2024/2025568 16 27 21 54 113 81 43 47 46 11 43 66
2025/20261.953 207 226 242 137 144 37 138 100 178 136 133 275
2026/2027158 96 62 0 0 0 0 0 0 0 0 0 0
Totale 3.254